15 results
10-K
2023 FY
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
oral formulation is being developed to potentially not require health care professional supervision, potentially improving patient compliance and ease … from payers such as government health care programs and insurance companies and achieve commercially attractive levels of pricing;
secure acceptance
8-K
EX-1.1
MIRA
Mira Pharmaceuticals Inc
7 Aug 23
MIRA Pharmaceuticals, Inc. Announces Pricing of $8.9 Million Initial
5:14pm
or of any other U.S. or foreign government or drug or medical device regulatory agency, or health care facility Institutional Review Board; each … regulatory agencies, or foreign health care facility Institutional Review Boards; and no investigational new drug application filed by or on behalf
424B4
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus supplement with pricing info
1:01pm
from payers such as government health care programs and insurance companies and achieve commercially attractive levels of pricing;
secure acceptance … of our product candidates from physicians, health care payers, patients, and the medical community;
create positive publicity surrounding our product
424B1
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus with pricing info
12:59pm
such as government health care programs and insurance companies and achieve commercially attractive levels of pricing;
secure acceptance of our product … candidates from physicians, health care payers, patients, and the medical community;
create positive publicity surrounding our product candidates;
manage our
S-1
eds to6azv
29 Jun 23
IPO registration
4:39pm
DRS/A
e827pimck8cbcen9s45
8 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
8odqbj oj3s71s7nccp
2 May 23
Draft registration statement (amended)
12:00am
D
eprnsnxp007 41a6
1 Aug 22
$3M in equity, sold $625K, 8 investors
5:10pm
D
d006uo9
1 Aug 22
$6.51M in equity, sold $6.51M, 76 investors
4:38pm
DRS
vv53e42gfl chbo0ko
29 Jun 22
Draft registration statement
12:00am
- Prev
- 1
- Next